Our results expected at the end of the project are:

1. Providing a reliable validated numerical model of the intraaneurysmal thrombosis mechanisms based on biological experiments.
2. Providing clinicians (partners HCL, CHU, CHUV) with a virtual tool to help in choosing the optimal stents based on relevant criteria issued from image processing and numerical simulation.
3. Providing stent manufacturers with strategies for optimal stent design.
4. Providing clinicians and scientists with an interactive end-user tool coupled to a medical collaborative tool, allowing efficient exchange of information.